ERBB2 and breast carcinoma: An analysis of the breast cancer phenotype in women with LFS found that 84% of invasive tumours were hormone responsive (ER and/or PR), with a majority of these also being positive for Her2/neu, figures which are higher than for a comparable non-LFS population [5].